Quarterly report [Sections 13 or 15(d)]

Related Party Transactions (Tables)

v3.25.1
Related Party Transactions (Tables)
3 Months Ended
Mar. 31, 2025
Related Party Transactions  
Schedule of effective date and PIK dividend or equity fee payable

​

​

​

​

​

​

​

​

​

​

​

​

PIK Dividend as

​

​

​

​

​

​

a % of fully

​

​

​

​

​

​

diluted

​

​

​

​

​

​

outstanding

​

Class of Stock

Partner Company/Subsidiary

    

Effective Date 1

    

capitalization

    

Issued

Avenue

​

February 17, 2015

 

2.5

%

Common Stock

Cellvation

​

October 31, 2016

 

2.5

%  

Common Stock

Checkpoint

​

March 17, 2015

 

-

%2  

Common Stock

Cyprium

​

March 13, 2017

 

2.5

%  

Common Stock

Helocyte

​

March 20, 2015

 

2.5

%  

Common Stock

Mustang

​

March 13, 2015

 

2.5

%  

Common Stock

Oncogenuity

​

April 22, 2020 3

​

2.5

%

Common Stock

Urica

​

November 7, 2017 3

 

2.5

%  

Common Stock

​

Note 1:

Represents the effective date of the Founders Agreement of each subsidiary/partner company. Each PIK dividend and equity fee is payable on the annual anniversary of the effective date of the original Founders Agreement or has since been amended to January 1 of each calendar year.

Note 2:

Instead of a PIK dividend, Checkpoint pays the Company an annual equity fee in shares of Checkpoint’s common stock equal to 2.5% of Checkpoint’s fully diluted outstanding capitalization.

Note 3:

Represents the Trigger Date, the date that the Fortress partner company/subsidiary first acquires, whether by license or otherwise, ownership rights in a product.

Schedule of PIK dividend or equity fee recorded

The Company has entered into Management Services Agreements (the “MSAs”) with certain of its partner companies/subsidiaries as described in the 2024 Form 10 K. The following table summarizes the effective date of each MSA and the annual consulting fee payable by the partner company/subsidiary to the Company in quarterly installments:

​

​

​

​

​

​

​

​

​

​

​

Annual MSA Fee

​

Partner Company/Subsidiary

    

Effective Date

    

(Income)/Expense

​

Avenue

​

February 17, 2015

​

 

500

​

Cellvation

​

October 31, 2016

​

 

500

​

Checkpoint

​

March 17, 2015

​

 

500

​

Cyprium

​

March 13, 2017

​

 

500

​

Helocyte

​

March 20, 2015

​

​

500

​

Mustang

​

March 13, 2015

​

 

500

​

Oncogenuity

​

February 10, 2017

​

​

500

​

Urica

​

November 7, 2017

​

​

500

​

Fortress

​

​

​

 

(4,000)

​

Consolidated (Income)/Expense

​

​

​

$

—

​

​